Diabetes linked to increased risks for primary outcome of cardiovascular death, MI, stroke and secondary outcomes
Additionally, among patients with Parkinson disease, type 2 diabetes tied to more rapid Parkinson progression
Maintaining treatment resulted in continued weight loss during additional 48 weeks compared with switching to placebo.
Prescriptions for short-acting hormonal methods, such as pills and injections, declined in the year after diabetes diagnosis
Intensive lifestyle intervention may be detrimental for overweight, obese patients with type 2 diabetes who have poor glycemic control
Please login or register first to view this content.